These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11892720)

  • 1. Heart rate variability as predictor of nonresponse to mirtazapine in panic disorder: a preliminary study.
    Slaap BR; Boshuisen ML; van Roon AM; den Boer JA
    Int Clin Psychopharmacol; 2002 Mar; 17(2):69-74. PubMed ID: 11892720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of mirtazapine in panic disorder: an open label pilot study with a single-blind placebo run-in period.
    Boshuisen ML; Slaap BR; Vester-Blokland ED; den Boer JA
    Int Clin Psychopharmacol; 2001 Nov; 16(6):363-8. PubMed ID: 11712626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mirtazapine in the treatment of panic disorder.
    Carli V; Sarchiapone M; Camardese G; Romano L; DeRisio S
    Arch Gen Psychiatry; 2002 Jul; 59(7):661-2. PubMed ID: 12090820
    [No Abstract]   [Full Text] [Related]  

  • 4. Mirtazapine versus fluoxetine in the treatment of panic disorder.
    Ribeiro L; Busnello JV; Kauer-Sant'Anna M; Madruga M; Quevedo J; Busnello EA; Kapczinski F
    Braz J Med Biol Res; 2001 Oct; 34(10):1303-7. PubMed ID: 11593305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
    Koran LM; Gamel NN; Choung HW; Smith EH; Aboujaoude EN
    J Clin Psychiatry; 2005 Apr; 66(4):515-20. PubMed ID: 15816795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with mirtazapine in the treatment of panic disorder.
    Carpenter LL; Leon Z; Yasmin S; Price LH
    Ann Clin Psychiatry; 1999 Jun; 11(2):81-6. PubMed ID: 10440525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirtazapine in the treatment of panic disorder: an open-label trial.
    Sarchiapone M; Amore M; De Risio S; Carli V; Faia V; Poterzio F; Balista C; Camardese G; Ferrari G
    Int Clin Psychopharmacol; 2003 Jan; 18(1):35-8. PubMed ID: 12490773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular variability in major depressive disorder and effects of imipramine or mirtazapine (Org 3770).
    Tulen JH; Bruijn JA; de Man KJ; Pepplinkhuizen L; van den Meiracker AH; Man in 't Veld AJ
    J Clin Psychopharmacol; 1996 Apr; 16(2):135-45. PubMed ID: 8690829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of mirtazapine in post-traumatic stress disorder.
    Connor KM; Davidson JR; Weisler RH; Ahearn E
    Int Clin Psychopharmacol; 1999 Jan; 14(1):29-31. PubMed ID: 10221639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart rate variability spectral analysis in patients with panic disorder compared with healthy controls.
    Diveky T; Prasko J; Latalova K; Grambal A; Kamaradova D; Silhan P; Obereigneru R; Salinger J; Opavsky J; Tonhajzerova I
    Neuro Endocrinol Lett; 2012; 33(2):156-66. PubMed ID: 22592196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial.
    Davidson JR; Weisler RH; Butterfield MI; Casat CD; Connor KM; Barnett S; van Meter S
    Biol Psychiatry; 2003 Jan; 53(2):188-91. PubMed ID: 12547477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mirtazapine in major depression with comorbid generalized anxiety disorder.
    Goodnick PJ; Puig A; DeVane CL; Freund BV
    J Clin Psychiatry; 1999 Jul; 60(7):446-8. PubMed ID: 10453798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mirtazapine: other indications.
    Falkai P
    J Clin Psychiatry; 1999; 60 Suppl 17():36-40; discussion 46-8. PubMed ID: 10446741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mirtazapine in the treatment of adolescents with major depression: an open-label, multicenter pilot study.
    Haapasalo-Pesu KM; Vuola T; Lahelma L; Marttunen M
    J Child Adolesc Psychopharmacol; 2004; 14(2):175-84. PubMed ID: 15319015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study.
    Winokur A; Sateia MJ; Hayes JB; Bayles-Dazet W; MacDonald MM; Gary KA
    Biol Psychiatry; 2000 Jul; 48(1):75-8. PubMed ID: 10913511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panic disorder, autonomic nervous system and dissociation - changes during therapy.
    Prasko J; Latalova K; Diveky T; Grambal A; Kamaradova D; Velartova H; Salinger J; Opavsky J; Silhan P
    Neuro Endocrinol Lett; 2011; 32(5):641-51. PubMed ID: 22167145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The side effects burden of extended imipramine treatment of panic disorder.
    Mavissakalian MR; Perel JM
    J Clin Psychopharmacol; 2000 Oct; 20(5):547-55. PubMed ID: 11001240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms.
    Theobald DE; Kirsh KL; Holtsclaw E; Donaghy K; Passik SD
    J Pain Symptom Manage; 2002 May; 23(5):442-7. PubMed ID: 12007762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.